BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12175432)

  • 1. Cost of medical injury in New Zealand: a retrospective cohort study.
    Brown P; McArthur C; Newby L; Lay-Yee R; Davis P; Briant R
    J Health Serv Res Policy; 2002 Jul; 7 Suppl 1():S29-34. PubMed ID: 12175432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs of medical injuries in Utah and Colorado.
    Thomas EJ; Studdert DM; Newhouse JP; Zbar BI; Howard KM; Williams EJ; Brennan TA
    Inquiry; 1999; 36(3):255-64. PubMed ID: 10570659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between complaints and quality of care in New Zealand: a descriptive analysis of complainants and non-complainants following adverse events.
    Bismark MM; Brennan TA; Paterson RJ; Davis PB; Studdert DM
    Qual Saf Health Care; 2006 Feb; 15(1):17-22. PubMed ID: 16456205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events in New Zealand public hospitals I: occurrence and impact.
    Davis P; Lay-Yee R; Briant R; Ali W; Scott A; Schug S
    N Z Med J; 2002 Dec; 115(1167):U271. PubMed ID: 12552260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic measurement of medical errors using a hospital claims database.
    David G; Gunnarsson CL; Waters HC; Horblyuk R; Kaplan HS
    Value Health; 2013; 16(2):305-10. PubMed ID: 23538182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Representative case series from New Zealand public hospital admissions in 1998--III: adverse events and death.
    Briant R; Buchanan J; Lay-Yee R; Davis P
    N Z Med J; 2006 Mar; 119(1231):U1909. PubMed ID: 16582971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventable in-hospital medical injury under the "no fault" system in New Zealand.
    Davis P; Lay-Yee R; Briant R; Scott A
    Qual Saf Health Care; 2003 Aug; 12(4):251-6. PubMed ID: 12897357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Public hospital admissions for treating complications of clinical care: incidence, costs and funding strategy.
    McNair P; Jackson T; Borovnicar D
    Aust N Z J Public Health; 2010 Jun; 34(3):330-3. PubMed ID: 20618279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse events in New Zealand public hospitals II: preventability and clinical context.
    Davis P; Lay-Yee R; Briant R; Ali W; Scott A; Schug S
    N Z Med J; 2003 Oct; 116(1183):U624. PubMed ID: 14581938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing prices for hospital pharmaceuticals: a successful strategy for New Zealand?
    Tordoff JM; Norris PT; Reith DM
    Value Health; 2005; 8(3):201-8. PubMed ID: 15877592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct medical costs of adverse events in Dutch hospitals.
    Hoonhout LH; de Bruijne MC; Wagner C; Zegers M; Waaijman R; Spreeuwenberg P; Asscheman H; van der Wal G; van Tulder MW
    BMC Health Serv Res; 2009 Feb; 9():27. PubMed ID: 19203365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence and cost of adverse events in Victorian hospitals 2003-04.
    Ehsani JP; Jackson T; Duckett SJ
    Med J Aust; 2006 Jun; 184(11):551-5. PubMed ID: 16768660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Representative case series from public hospital admissions 1998 I: drug and related therapeutic adverse events.
    Briant R; Ali W; Lay-Yee R; Davis P
    N Z Med J; 2004 Jan; 117(1188):U747. PubMed ID: 14999306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Errors in health care management: what do they cost?
    Rigby KD; Litt JC
    Qual Health Care; 2000 Dec; 9(4):216-21. PubMed ID: 11101706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the costs of hospital-acquired infections in New Zealand.
    Graves N; Nicholls TM; Morris AJ
    Infect Control Hosp Epidemiol; 2003 Mar; 24(3):214-23. PubMed ID: 12683515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient dissatisfaction recorded in hospital notes in New Zealand: their occurrence and pattern.
    Davis P; Lay-Yee R; Briant R
    N Z Med J; 2008 May; 121(1273):51-9. PubMed ID: 18480886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical adverse events, risk management, and malpractice outcome: morbidity and mortality review is not enough.
    Morris JA; Carrillo Y; Jenkins JM; Smith PW; Bledsoe S; Pichert J; White A
    Ann Surg; 2003 Jun; 237(6):844-51; discussion 851-2. PubMed ID: 12796581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compensation for medical injury in New Zealand: does "'no-fault" increase the level of claims making and reduce social and clinical selectivity?
    Davis P; Lay-Yee R; Fitzjohn J; Hider P; Briant R; Schug S
    J Health Polit Policy Law; 2002 Oct; 27(5):833-54. PubMed ID: 12465781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of the Agency for Healthcare Research and Quality Patient Safety Indicators for children's hospitals.
    Sedman A; Harris JM; Schulz K; Schwalenstocker E; Remus D; Scanlon M; Bahl V
    Pediatrics; 2005 Jan; 115(1):135-45. PubMed ID: 15579669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injury: the medical and related costs in New Zealand 1990.
    Phillips DE; Langley JD; Marshall SW
    N Z Med J; 1993 Jun; 106(957):215-7. PubMed ID: 8367074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.